14 results match your criteria: "Empire Eye and Laser Center[Affiliation]"
Ophthalmol Ther
December 2024
Research Department, Empire Eye and Laser Center, Bakersfield, CA, USA.
Introduction: This study is a prospective, randomized, subject/evaluator-masked clinical trial in a single-center clinical setting. The purpose of the study is to compare the clinical performance of Tecnis Symfony Optiblue IOL (models ZXR00V and ZXW150) with violet light filter (VLF) and manufacturing improvements versus Tecnis Symfony IOL (models ZXR00 and ZXT150) with ultraviolet light filter (UVF) in patients undergoing cataract surgery.
Methods: Patients with cataracts aged ≥ 22 years were randomly assigned 1:1 to bilateral implantation with ZXR00V/ZXW150 (VLF group) or ZXR00/ZXT150 (UVF group).
Ophthalmol Ther
October 2023
Johnson & Johnson Surgical Vision, Inc., Irvine, CA, USA.
Introduction: Patients implanted with a range-of-vision intraocular lens (IOL) (multifocal or extended depth of focus, EDOF) may be more susceptible to visual disturbances from poor tear film quality, and prophylactic treatment of meibomian gland dysfunction (MGD) has been recommended. The purpose was to evaluate whether vectored thermal pulsation (LipiFlow™) treatment prior to cataract surgery with a range-of-vision IOL safely improves postoperative outcomes.
Methods: This is a prospective, randomized, open-label, crossover, multicenter study of patients with mild-to-moderate MGD and cataract.
J Cataract Refract Surg
August 2023
From the Empire Eye and Laser Center, Bakersfield, California (Chang); Texas Eye and Laser Center, Hurst, Texas (Hu); Lehmann Eye Center, Nacogdoches, Texas (Lehmann); Vance Thompson Vision Clinic, Sioux Falls, South Dakota (Thompson); Johnson & Johnson Vision, Santa Ana, California (Tsai, Thomas).
Purpose: To compare the clinical performance of TECNIS Synergy intraocular lens (IOL), model ZFR00V, vs TECNIS IOL, model ZCB00, in cataract patients.
Setting: Multicenter clinical setting.
Design: Prospective, randomized, subject/evaluator-masked clinical trial.
Ophthalmol Ther
June 2023
Johnson & Johnson Surgical Vision, Irvine, CA, USA.
Introduction: The aim of this study was to evaluate the safety and efficacy of a violet-light filtering intraocular lens (IOL) compared to a colorless IOL control.
Methods: This was a prospective, bilateral, randomized, comparative, patient/evaluator-masked multi-center clinical trial at 12 sites in the USA. Patients underwent standard small-incision phacoemulsification cataract extraction.
Purpose: To assess the experimental visual performance and dysphotopsia characteristics of the new Tecnis Symfony OptiBlue extended-depth-of-focus with violet light-filtering (ZXR00V) intraocular lens (IOL) compared with the colorless Tecnis Symfony (ZXR00) IOL.
Methods: Range of vision was assessed with simulated visual acuity defocus curves, predicted by white light through focus modulation transfer function (MTF) measurements. The clinical visual acuity defocus curve of the ZXR00 IOL was used to validate the predicted range of vision.
Clin Ophthalmol
December 2022
Johnson & Johnson Surgical Vision, Inc., Irvine, CA, USA.
Purpose: To evaluate 3-month rotational stability, and visual and refractive outcomes of a toric intraocular lens (IOL) with frosted haptics.
Patients And Methods: A post-market, prospective, multi-center, single-arm, open-label study conducted at seven clinical sites in the United States. Two hundred and two eyes of 133 subjects with unilateral or bilateral cataracts and corneal astigmatism were implanted with the Tecnis Toric II IOL, Models ZCU150 to 600 (Johnson & Johnson Surgical Vision, Inc.
Clin Ophthalmol
August 2022
Johnson & Johnson Surgical Vision, Inc, Santa Ana, CA, USA.
Purpose: The purpose of this first in-human study was to evaluate the overall clinical performance of the VERITAS™ Vision System in patients scheduled to undergo cataract extraction and to confirm overall surgeon acceptability.
Patients And Methods: This prospective, open-label multinational study included adults with cataracts scheduled for planned cataract extraction and posterior chamber IOL implantation. Standard small-incision phacoemulsification cataract surgery with the VERITAS Vision System was conducted.
Clin Ophthalmol
March 2022
Johnson & Johnson Surgical Vision, Inc., Irvine, CA, USA.
Purpose: Investigator feedback was used to assess the clinical use of the LipiFlow System with the new translucent Activator Clear to successfully complete LipiFlow treatments.
Patients And Methods: This was a prospective, open-label clinical investigation. A total of 88 eyes (44 subjects) were treated using the LipiFlow System with the new Activator Clear.
Clin Ophthalmol
September 2021
University of California, Davis Eye Center, Sacramento, CA, USA.
Presbyopia, a loss of accommodative ability associated with aging, is a significant cause of vision impairment globally. At the clinical level, it is a frustrating and difficult issue that negatively impacts patients' quality of life. Less appreciated is the fact that loss of accommodative ability and its current treatments methods may present safety concerns, for example, increasing the risk of falls.
View Article and Find Full Text PDFJ Cataract Refract Surg
March 2022
From the Empire Eye and Laser Center, Bakersfield, California (Chang); Johnson & Johnson Vision, Santa Ana, California (Janakiraman, Smith, Buteyn, Domingo); Jones Eye Clinic, Sioux City, Iowa (Jones); Scott & Christie and Associates, PC, Cranberry Township, Pennsylvania (Christie).
Purpose: To compare the effectiveness and safety of the TECNIS Symfony intraocular lens (IOL; ZXR00) with the TECNIS 1-piece monofocal IOL (ZCB00).
Setting: 15 sites in the United States.
Design: Prospective, randomized, patient-masked/evaluator-masked clinical trial.
Am J Ophthalmol
May 2021
Waring Vision Institute, Mt. Pleasant, South Carolina, USA.
Purpose: To characterize crystalline lens dimensions derived from in vivo spectral-domain optical coherence tomography (SD-OCT) and identify associations among these parameters, ocular biometry, and age.
Methods: In this retrospective study, lens thickness (LT), lens diameter (LD), and lens volume (LV) were measured intraoperatively using SD-OCT in 293 eyes undergoing lens surgery. Correlations among LT, LD, LV, age, axial length (AL), and anterior chamber depth (ACD) were analyzed.
J Cataract Refract Surg
December 2019
Johnson & Johnson Surgical Vision, Inc., Santa Ana, California, USA.
Purpose: To compare the safety and effectiveness of bacterially derived and animal-derived sodium hyaluronate 2.3% ophthalmic viscosurgical devices (OVD) (Healon5 PRO and Healon5, respectively) in cataract surgery.
Setting: United States multicenter study.
Clin Ophthalmol
August 2016
Empire Eye and Laser Center, Bakersfield, CA, USA.
Purpose: The aim of the study is to evaluate the visual acuity and patient satisfaction at varied distances under photopic and mesopic lighting conditions in patients bilaterally implanted with aspheric diffractive multifocal one-piece intraocular lenses.
Methods: In this retrospective-prospective study, 16 patients with a mean age of 66.2±9.
Am J Ophthalmol
November 2014
Medical University of South Carolina, Storm Eye Institute, Charleston, South Carolina; Department of Bioengineering and Science, Clemson University, Clemson, South Carolina.
Purpose: To describe the inconsistencies in definition, application, and usage of the ocular reference axes (optical axis, visual axis, line of sight, pupillary axis, and topographic axis) and angles (angle kappa, lambda, and alpha) and to propose a precise, reproducible, clinically defined reference marker and axis for centration of refractive treatments and devices.
Design: Perspective.
Methods: Literature review of papers dealing with ocular reference axes, angles, and centration.